Research Expert: Sarah Overall
  • Published: Oct 2024
  • Pages: 150
  • SKU: IRTNTR77722

  • growing demand for non-invasive drug delivery methods is driving the Transdermal Patches Market

    Latest News:- Transdermal Patches Market: Pain management is expected to lead the Application segment during 2024-2028

    Technavio analyzes that the Transdermal Patches Market is expected to grow at a CAGR of 5.65% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.00 billion.There are various factors that contribute to the growth of the market. The transdermal patches market is experiencing significant growth due to the increasing preference for non-invasive drug delivery methods. Patients are increasingly seeking alternatives to traditional methods such as injections and oral medications, which can be inconvenient or come with unwanted side effects. Transdermal patches offer a discreet, convenient, and effective solution for administering medications through the skin, making them an attractive option for various therapeutic applications. The market is expected to continue expanding as technology advances and new applications for transdermal patches are discovered.

    Transdermal patches represent a groundbreaking innovation in pain management, providing a targeted and convenient solution for various types of pain. These patches function by delivering medications directly through the skin, ensuring systemic absorption and extended relief. Key therapeutic categories in transdermal patches include opioids, NSAIDs, lidocaine, and other analgesics. The global market for transdermal patches in pain management is experiencing significant growth, fueled by the escalating prevalence of chronic pain conditions, such as arthritis, neuropathic pain, and musculoskeletal disorders, as well as the aging population and increasing healthcare expenditures. The multi-layer drug-in-adhesive segment is a notable market trend, offering enhanced drug delivery and adhesion properties. 

    Know which region is leading the market growth by requesting a sample report

    Transdermal Patches Market Segmentation

    • Application
      • Pain management
      • Central nervous system disorders
      • Hormonal application
      • Cardiovascular diseases
      • Others
    • End-user
      • Homecare
      • Hospitals and clinics
    • Geography
      • North America
      • Europe
      • Asia
      • Rest of World (ROW)

    Top Performing Companies

    As per our research findings, here are some of the key competitors that are leading the industry

    • Alvogen Iceland ehf
    • Boehringer Ingelheim International GmbH
    • Endo International Plc
    • Hisamitsu Pharmaceutical Co. Inc.
    • IontoPatch
    • Johnson and Johnson Services Inc.
    • Lead Chemical Co. Ltd.
    • Luye Pharma Group Ltd.
    • Medherant Ltd.
    • Mundipharma International Ltd.
    • Nitto Denko Corp.
    • Novartis AG
    • Purdue Pharma LP
    • Sparsha Pharma International Pvt. Ltd.
    • Teva Pharmaceutical Industries Ltd.
    • Viatris Inc.
    • AdhexPharma SAS
    • Agile Therapeutics Inc.
    • Bayer AG
    • Evernow Inc.

    Find out what is trending in the market by accessing the free PDF report

    Research Analysis Overview

    Transdermal patches, a non-invasive method for medication delivery, have gained popularity in managing chronic illnesses such as diabetes, hypertension, and pain-related conditions. These patches, which use adhesive technology to adhere to the skin, allow for controlled dosing and prolonged therapeutic effects. Technological advancements have led to the development of electronic and mechanical transdermal patches, offering alternatives to traditional injections. The opioid epidemic has increased the demand for non-addictive pain management techniques, making transdermal patches an attractive option. Analgesic patches, which deliver medication through the skin directly into the bloodstream, offer a more convenient and cost-effective solution compared to frequent healthcare facility visits and medication failures. Chronic diseases, particularly those affecting the elderly population, can benefit greatly from the use of transdermal patches, ensuring consistent medication adherence and improved patient outcomes.

    Market Research Overview

    The Transdermal Patches Market is a significant segment within the global Pharmaceuticals Industry, encompassing entities involved in Research and Development (R&D) or manufacturing of analgesic patches and other transdermal medications. According to Technavio, the Pharmaceuticals Market, which includes companies producing generic and non-generic drugs, veterinary drugs, and associated equipment and services, is a key constituent of the broader Healthcare Industry. The expansion of the Pharmaceuticals Market will be influenced by several factors, including the increasing global geriatric population, technological advancements in patch design and application, and the rising costs of traditional injection-based pain management techniques. These factors contribute to the growing demand for effective, cost-efficient, and convenient pain management solutions, such as transdermal patches, in the healthcare landscape.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

    Reasons to Consider Purchasing Technavio Market Research Report

    • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

    • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

    • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

    Contacts

    Technavio Research
    Jesse Maida
    Media & Marketing Executive
    US: +1 844 364 1100
    UK: +44 203 893 3200
    Email: media@technavio.com
    Website: www.technavio.com/

    Read News Read Less
    Interested in this report?
    Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.

Document